NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 179 filers reported holding NOVAVAX INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $3,356,000 | +18.7% | 400,000 | 0.0% | 0.66% | +20.4% |
Q3 2015 | $2,828,000 | -36.5% | 400,000 | 0.0% | 0.55% | -13.4% |
Q2 2015 | $4,456,000 | +34.7% | 400,000 | 0.0% | 0.63% | +38.5% |
Q1 2015 | $3,308,000 | -2.1% | 400,000 | -29.8% | 0.46% | -0.9% |
Q4 2014 | $3,380,000 | – | 570,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |